Bugs as Drugs: Engineered Gut Bacteria Show Promise Against Pancreatic Cancer | Newswise
Likely Human
Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major reason is that pancreatic tumors often create a “cold” tumor microenvironment, where the tumor prevents immune cells from mounting a strong attack.In a new study published in Science Advances, researchers at the University of Chicago report a promising new strategy to overcome this barrier using BifidoSumIL-2, an engineered bacterial strain of Bifidobacte
The Verdict
ClassificationLikely Human
ConfidenceMedium confidence
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/33094979-93b0-4edd-a526-6d78bef9435f)